Nu-Med Plus (NUMD) Cash & Equivalents (2011 - 2026)
Nu-Med Plus (NUMD) reported Cash & Equivalents of $5,409 for Q2 2026, up 526.8% from $863.00 a year earlier.
Powered by 
Analysis
Nu-Med Plus (NUMD) Cash & Equivalents (2011 - 2026) Analysis & Trends
At the end of FY2025, Nu-Med Plus posted Cash & Equivalents of $661.00, down 72.1% from FY2024.
- Cash & Equivalents has declined for three consecutive years, with a five-year compound annual growth rate of -67.7% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $2,373 in FY2024 (-65.1%), $6,806 in FY2023 (-90.7%), $73,195 in FY2022 (+526.9%) and $11,675 in FY2021 (-93.8%).
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents since Q1 2024.
- Year over year, Cash & Equivalents gained in 1 of the last seven quarters, with growth averaging 19.0%.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2022 (growth of 526.9%); the low point was Q1 2022 (a decline of 98.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 2.76 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 2.91 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 708.00 Mn |
| 10 | Nu-Med Plus | 835,484.67 | 826,603.67 | - | 5,409.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,409.00 |
| Dec 31, 2025 | 661.00 |
| Sep 30, 2025 | 1,948.00 |
| Jun 30, 2025 | 863.00 |
| Mar 31, 2025 | 2,373.00 |
| Dec 31, 2024 | 2,373.00 |
| Sep 30, 2024 | 4,041.00 |
| Jun 30, 2024 | 4,041.00 |
| Mar 31, 2024 | 6,356.00 |
| Dec 31, 2023 | 6,806.00 |
| Sep 30, 2023 | 11,088.00 |
| Jun 30, 2023 | 29,957.00 |
| Mar 31, 2023 | 53,029.00 |
| Dec 31, 2022 | 73,195.00 |
| Sep 30, 2022 | 628.00 |
| Mar 31, 2022 | 2,537.00 |
| Dec 31, 2021 | 11,675.00 |
| Sep 30, 2021 | 31,840.00 |
| Jun 30, 2021 | 72,831.00 |
| Mar 31, 2021 | 139,265.00 |
API Access
Nu-Med Plus Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NUMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NUMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NUMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();